Source Date | Board Meeting Date | Details |
01-Apr-2024
|
04-Apr-2024
|
Preferential Issue of shares & Inter alia, to consider and approve:- (1) proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights / qualified institutional placement or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
05-Feb-2024
|
13-Feb-2024
|
Quarterly Results
|
20-Dec-2023
|
26-Dec-2023
|
Preferential Issue of shares & Inter-alia, to discuss, consider and evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a preferential / rights or any other permissible mode / and / or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
02-Nov-2023
|
09-Nov-2023
|
Quarterly Results
|
07-Aug-2023
|
14-Aug-2023
|
Quarterly Results
|
26-Jun-2023
|
28-Jun-2023
|
Preferential Issue of shares & Issue Of Warrants Inter alia, to consider and approve the proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a rights / preferential or any other permissible mode / and/or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Company.
|
23-May-2023
|
30-May-2023
|
Final Dividend & Audited Results
|
06-Feb-2023
|
13-Feb-2023
|
Quarterly Results
|
10-Jan-2023
|
13-Jan-2023
|
Preferential Issue of shares & Issue Of Warrants inter-alia, to discuss, consider and evaluate proposal for raising of funds by way of issue of equity shares, convertibles and / or any other eligible securities, on a rights / preferential or any other permissible mode / and/or combination thereof as may be considered appropriate, subject to all such regulatory / statutory approvals as may be required including the approval of shareholders of the Compan
|
07-Nov-2022
|
12-Nov-2022
|
Quarterly Results
|